Medpace (NASDAQ: MEDP) insider sells 15,978 shares in August trades
Rhea-AI Filing Summary
Medpace Holdings, Inc. (MEDP) reported that President & CEO and ten percent owner August J. Troendle sold a total of 15,978 shares of common stock. On August 21, 2026, he sold 13,995 shares at a weighted average price of $624.45 per share, with individual trades ranging from $620.00 to $628.685, effected under a limit order placed during an open window period. On August 24, 2026, he sold 1,983 shares at a weighted average price of $620.23 per share, with trades ranging from $620.00 to $621.25.
The filing also reports an indirect holding of 4,733,019 shares of Medpace common stock held by Medpace Investors, LLC, for which Troendle is the sole manager with sole voting and investment control. He may be deemed to indirectly beneficially own these securities but disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 15,978 shares
Net Sell
3 txns
Insider
Troendle August J.
Role
President & CEO
Sold
15,978 shs ($9.97M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F3 | 1,983 | $620.23 | $1.23M |
| Sale | Common Stock F1, F2 | 13,995 | $624.45 | $8.74M |
| holding | Common Stock F4 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 545,217 shares (Direct);
Common Stock — 4,733,019 shares (Indirect, By Medpace Investors, LLC)
Footnotes (4)
- F1. The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
- F2. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $628.685. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- F3. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $621.25. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- F4. The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Key Figures
Shares sold on August 21, 2026: 13,995 shares
Weighted average price on August 21, 2026: $624.45 per share
Shares sold on August 24, 2026: 1,983 shares
+3 more
6 metrics
Shares sold on August 21, 2026
13,995 shares
Common stock sale by August J. Troendle
Weighted average price on August 21, 2026
$624.45 per share
Sales ranged from $620.00 to $628.685
Shares sold on August 24, 2026
1,983 shares
Common stock sale by August J. Troendle
Weighted average price on August 24, 2026
$620.23 per share
Sales ranged from $620.00 to $621.25
Total shares sold
15,978 shares
Aggregate of reported sales on August 21 and 24, 2026
Indirect shares held by Medpace Investors, LLC
4,733,019 shares
Indirect ownership position associated with August J. Troendle
Key Terms
weighted average price, limit order, pecuniary interest, indirectly beneficially own
4 terms
weighted average price financial
"The reported price is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
limit order financial
"effected pursuant to a limit order placed by the Reporting Person"
A limit order is an instruction to buy or sell a stock only at a specific price or better, giving you control over the exact price you pay or receive. It matters to investors because it acts like a price guard—similar to setting a maximum you’ll pay for an item at a store—so you avoid unexpected prices, though the trade may not happen if the market never reaches your limit.
pecuniary interest financial
"disclaims beneficial ownership of such securities except to the extent of his pecuniary interest"
indirectly beneficially own financial
"may be deemed to indirectly beneficially own the securities of the Issuer held by MPI"
FAQ
What insider transaction did MEDP report for August J. Troendle?
Medpace (MEDP) reported that August J. Troendle sold 15,978 shares of common stock in open market or private transactions on August 21 and 24, 2026, according to a Form 4 filing.
Were the MEDP insider sales made under a Rule 10b5-1 trading plan?
The Form 4 states that the transactions were effected under a limit order placed during an open window period. The filing’s Rule 10b5-1 checkbox is not marked as being under a 10b5-1 plan.
What is August J. Troendle’s indirect MEDP ownership through Medpace Investors, LLC?
The filing reports 4,733,019 MEDP shares held indirectly through Medpace Investors, LLC. Troendle is the sole manager with sole voting and investment control and may be deemed to beneficially own these shares, while disclaiming ownership beyond his pecuniary interest.
AI-generated analysis. How Rhea-AI works. Not financial advice.
